162 related articles for article (PubMed ID: 34967576)
1. Genomic Understanding Reveals the Important Role of FGFR2 as Paeoniflorin Target for Circumventing Breast Cancer Resistance to Tamoxifen.
Wibowo MA; Nugroho EP; Hermawan A
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3949-3958. PubMed ID: 34967576
[TBL] [Abstract][Full Text] [Related]
2. MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis.
Azzahra SNA; Hanif N; Hermawan A
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2341-2350. PubMed ID: 35901340
[TBL] [Abstract][Full Text] [Related]
3. The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining.
Xu D; Zhang Y; Jin F
BMC Cancer; 2021 Dec; 21(1):1321. PubMed ID: 34886806
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Fibroblast Growth Factor Receptor (FGFR) Family Genes in Breast Cancer by Integrating Online Databases and Bioinformatics.
Zhou Z; Wu B; Tang X; Ke R; Zou Q
Med Sci Monit; 2020 May; 26():e923517. PubMed ID: 32381997
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells.
Cun J; Yang Q
Biomed Pharmacother; 2018 Nov; 107():117-128. PubMed ID: 30086458
[TBL] [Abstract][Full Text] [Related]
6. Paeoniflorin, the Main Monomer Component of Paeonia lactiflora, Exhibits Anti-inflammatory Properties in Osteoarthritis Synovial Inflammation.
Chen P; Zhou J; Ruan AM; Ma YF; Wang QF
Chin J Integr Med; 2024 May; 30(5):433-442. PubMed ID: 37999887
[TBL] [Abstract][Full Text] [Related]
7. Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis.
Wang Y; Wang Q; Li X; Luo G; Shen M; Shi J; Wang X; Tang L
Drug Des Devel Ther; 2021; 15():245-257. PubMed ID: 33519190
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.
Zhu QN; Renaud H; Guo Y
Hereditas; 2018; 155():17. PubMed ID: 29371858
[TBL] [Abstract][Full Text] [Related]
9. An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors.
Huang L; Zhao S; Frasor JM; Dai Y
PLoS One; 2011; 6(7):e22274. PubMed ID: 21789246
[TBL] [Abstract][Full Text] [Related]
10. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer.
Wang Y; Gong X; Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386
[TBL] [Abstract][Full Text] [Related]
11. Identifying differentially expressed genes and screening small molecule drugs for lapatinib-resistance of breast cancer by a bioinformatics strategy.
Zhuo WL; Zhang L; Xie QC; Zhu B; Chen ZT
Asian Pac J Cancer Prev; 2014; 15(24):10847-53. PubMed ID: 25605188
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen.
Hermawan A; Putri H; Hanif N; Fatimah N; Prasetio HH
Front Oncol; 2022; 12():1019025. PubMed ID: 36601474
[TBL] [Abstract][Full Text] [Related]
13. Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen.
Ibadurrahman W; Hanif N; Hermawan A
J Genet Eng Biotechnol; 2022 Apr; 20(1):66. PubMed ID: 35482141
[TBL] [Abstract][Full Text] [Related]
14. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
15. Identification of key genes involved in tamoxifen-resistant breast cancer using bioinformatics analysis.
Wang X; Wang S
Transl Cancer Res; 2021 Dec; 10(12):5246-5257. PubMed ID: 35116374
[TBL] [Abstract][Full Text] [Related]
16. Integrative bioinformatics analysis reveals miR-494 and its target genes as predictive biomarkers of trastuzumab-resistant breast cancer.
Hermawan A; Putri H
J Egypt Natl Canc Inst; 2020 Apr; 32(1):16. PubMed ID: 32372307
[TBL] [Abstract][Full Text] [Related]
17. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
Tang D; Zhao X; Zhang L; Wang Z; Wang C
J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
[TBL] [Abstract][Full Text] [Related]
18. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
19. Multi-time scale transcriptomic analysis on the dynamic process of tamoxifen resistance development in breast cancer cell lines.
Zeng Q; Lin X; Chen H; Yan Y; Wang X
Breast Cancer; 2022 May; 29(3):458-467. PubMed ID: 35041152
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line.
Li W; Wang S; Qiu C; Liu Z; Zhou Q; Kong D; Ma X; Jiang J
J Transl Med; 2019 Feb; 17(1):58. PubMed ID: 30813939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]